FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080237392> ?p ?o ?g. }

• W2080237392 endingPage "520" @default.
• W2080237392 startingPage "514" @default.
• W2080237392 abstract "To evaluate the efficacy of solifenacin succinate in Parkinson's disease (PD) patients suffering from overactive bladder (OAB).Urinary dysfunction is a commonly encountered non-motor feature in PD that significantly impacts patient quality of life.This was a double-blind, randomized, placebo-controlled, 3-site study with an open label extension phase to determine the efficacy of solifenacin succinate in idiopathic PD patients with OAB. Patients were randomized to receive solifenacin succinate 5-10 mg daily or placebo for 12 weeks followed by an 8-week open label extension. The primary outcome measure was the change in the mean number of micturitions per 24 h period. Secondary outcome measures included the change in the mean number of urinary incontinence episodes and the mean number of nocturia episodes.Twenty-three patients were randomized in the study. There was no significant improvement in the primary outcome measure in the double-blind phase, but there was an improvement in the number of micturitions per 24 h period in the solifenacin succinate group compared to placebo at a mean dose of 6 mg/day (p = 0.01). In the open label phase, the mean number of urinary incontinence episodes per 24 h period decreased (p = 0.03), as did the number of nocturia episodes per 24 h period (p = 0.01). Adverse events included constipation and xerostomia, which resolved after treatment was discontinued.In this pilot trial, solifenacin succinate treatment led to an improvement in urinary incontinence, despite persistence in other OAB symptoms." @default.
• W2080237392 created "2016-06-24" @default.
• W2080237392 creator A5008243996 @default.
• W2080237392 creator A5009493288 @default.
• W2080237392 creator A5010308524 @default.
• W2080237392 creator A5025937811 @default.
• W2080237392 creator A5036485745 @default.
• W2080237392 creator A5036662910 @default.
• W2080237392 creator A5068816464 @default.
• W2080237392 creator A5070407028 @default.
• W2080237392 creator A5088238884 @default.
• W2080237392 date "2015-05-01" @default.
• W2080237392 modified "2023-10-02" @default.
• W2080237392 title "Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease" @default.
• W2080237392 cites W1998779327 @default.
• W2080237392 cites W2002929092 @default.
• W2080237392 cites W2008560062 @default.
• W2080237392 cites W2027340686 @default.
• W2080237392 cites W2028950772 @default.
• W2080237392 cites W2051439239 @default.
• W2080237392 cites W2055583849 @default.
• W2080237392 cites W2058976712 @default.
• W2080237392 cites W2071038968 @default.
• W2080237392 cites W2076029586 @default.
• W2080237392 cites W2081812660 @default.
• W2080237392 cites W2113296104 @default.
• W2080237392 cites W2117549994 @default.
• W2080237392 cites W2123652212 @default.
• W2080237392 cites W2130736332 @default.
• W2080237392 cites W2131770336 @default.
• W2080237392 cites W2140757158 @default.
• W2080237392 cites W2147647029 @default.
• W2080237392 cites W2156261151 @default.
• W2080237392 cites W2165828096 @default.
• W2080237392 doi "https://doi.org/10.1016/j.parkreldis.2015.02.025" @default.
• W2080237392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25814050" @default.
• W2080237392 hasPublicationYear "2015" @default.
• W2080237392 type Work @default.
• W2080237392 sameAs 2080237392 @default.
• W2080237392 citedByCount "59" @default.
• W2080237392 countsByYear W20802373922015 @default.
• W2080237392 countsByYear W20802373922016 @default.
• W2080237392 countsByYear W20802373922017 @default.
• W2080237392 countsByYear W20802373922018 @default.
• W2080237392 countsByYear W20802373922019 @default.
• W2080237392 countsByYear W20802373922020 @default.
• W2080237392 countsByYear W20802373922021 @default.
• W2080237392 countsByYear W20802373922022 @default.
• W2080237392 countsByYear W20802373922023 @default.
• W2080237392 crossrefType "journal-article" @default.
• W2080237392 hasAuthorship W2080237392A5008243996 @default.
• W2080237392 hasAuthorship W2080237392A5009493288 @default.
• W2080237392 hasAuthorship W2080237392A5010308524 @default.
• W2080237392 hasAuthorship W2080237392A5025937811 @default.
• W2080237392 hasAuthorship W2080237392A5036485745 @default.
• W2080237392 hasAuthorship W2080237392A5036662910 @default.
• W2080237392 hasAuthorship W2080237392A5068816464 @default.
• W2080237392 hasAuthorship W2080237392A5070407028 @default.
• W2080237392 hasAuthorship W2080237392A5088238884 @default.
• W2080237392 hasConcept C126322002 @default.
• W2080237392 hasConcept C126894567 @default.
• W2080237392 hasConcept C142724271 @default.
• W2080237392 hasConcept C168563851 @default.
• W2080237392 hasConcept C197934379 @default.
• W2080237392 hasConcept C204787440 @default.
• W2080237392 hasConcept C27081682 @default.
• W2080237392 hasConcept C2777333188 @default.
• W2080237392 hasConcept C2777912814 @default.
• W2080237392 hasConcept C2778531004 @default.
• W2080237392 hasConcept C2778941218 @default.
• W2080237392 hasConcept C2779502394 @default.
• W2080237392 hasConcept C2781112942 @default.
• W2080237392 hasConcept C71924100 @default.
• W2080237392 hasConcept C77411442 @default.
• W2080237392 hasConceptScore W2080237392C126322002 @default.
• W2080237392 hasConceptScore W2080237392C126894567 @default.
• W2080237392 hasConceptScore W2080237392C142724271 @default.
• W2080237392 hasConceptScore W2080237392C168563851 @default.
• W2080237392 hasConceptScore W2080237392C197934379 @default.
• W2080237392 hasConceptScore W2080237392C204787440 @default.
• W2080237392 hasConceptScore W2080237392C27081682 @default.
• W2080237392 hasConceptScore W2080237392C2777333188 @default.
• W2080237392 hasConceptScore W2080237392C2777912814 @default.
• W2080237392 hasConceptScore W2080237392C2778531004 @default.
• W2080237392 hasConceptScore W2080237392C2778941218 @default.
• W2080237392 hasConceptScore W2080237392C2779502394 @default.
• W2080237392 hasConceptScore W2080237392C2781112942 @default.
• W2080237392 hasConceptScore W2080237392C71924100 @default.
• W2080237392 hasConceptScore W2080237392C77411442 @default.
• W2080237392 hasIssue "5" @default.
• W2080237392 hasLocation W20802373921 @default.
• W2080237392 hasLocation W20802373922 @default.
• W2080237392 hasOpenAccess W2080237392 @default.
• W2080237392 hasPrimaryLocation W20802373921 @default.
• W2080237392 hasRelatedWork W134550863 @default.
• W2080237392 hasRelatedWork W1507298952 @default.
• W2080237392 hasRelatedWork W2096193998 @default.
• W2080237392 hasRelatedWork W2125559506 @default.

• next